The rise of Sildenafil initially fueled a surge for major pharmaceutical companies, however recent changes present a uncertain scenario for those considering a stake. Generic alternatives are reducing profits, and https://emilyfawa320645.bloggip.com/41594596/sildenafil-and-big-pharma-a-risky-bet